Single-Month Rebound of 70%, 3 Institutions File for ETF: Deconstructing the Data Truth Behind INJ's Surge

Original author: Gemini, TechFlow

In crypto, few projects manage to crawl out of the "grave" of a previous cycle twice.

For veterans who lived through the 2023–2024 market, Injective ($INJ) was once a name that triggered FOMO. Back then, riding the halo of being an "on-chain derivatives public chain" and flanked by market makers of all stripes, it squeezed shorts all the way up to an all-time high of $52.6.

But in the long stretch of dead time that followed, it also became one of the most brutally beaten fallen stars; the price slid all the way down to the $4 range earlier this year, erasing more than 85% of its market cap, with the community as quiet as a ghost town.

And that situation once again gave capital room to hype up old coins anew.

Today (October 16), INJ surged more than 23% on heavy volume in a single day, with one big green candle taking it straight to $9.16; and if you zoom out on the chart, you'll be surprised to find that over the past month, when no one was paying attention, this "old demon coin" had quietly rallied nearly 70% off the bottom, with perpetual futures open interest swelling by $35 million within a few days.

If you stretch the timeline out further, you'll realize this is actually a carefully laid narrative play built around "clearing U.S. compliant ETF hurdles + an institutional RWA pivot."

Ditching the Crypto Ruffian's Cloak, Moving the Card Table Into the White House

The climax of this short squeeze came on Wednesday (October 14) in Washington.

That day, Injective co-founder and CEO Eric Chen, suited up in a full business suit, brought his general counsel and head of policy along and paid visits, one by one, to senior officials at the White House, the U.S. Securities and Exchange Commission (SEC), and the Commodity Futures Trading Commission (CFTC).

When the news got back to crypto, the bulls got excited, and Crypto Twitter began treating it as a bullish signal for mainstream compliance.

In the crypto market, founders making a trip to Washington to "show face" is nothing rare; what's rare is that when Eric Chen knocked on those doors this time, he was actually clutching a few compliance cards that had Wall Street sitting up and taking notice.

Looking back over the past two months, you'll find the Injective team has quietly been doing one thing the whole time:

Washing away its old "casino base" for retail traders punting altcoin perpetuals, and rebranding it as an "institutional RWA dedicated chain" backed by the U.S. government.

1. First, on August 19 of this year, Injective's institutional services entity quietly secured official registration as a SEC-registered Transfer Agent.

This license carries enormous weight, meaning it is legally authorized to record ownership and process dividends for tokenized securities on-chain.

1. Then, in September and early October, three institutions — 21Shares, Canary Capital, and REX-Osprey — queued up to file INJ spot and staking ETF applications with the SEC; Canary even went so far as to propose that 90% of the ETF's INJ be staked on-chain to earn yield.
2. Then yesterday, October 15, the day after the CEO walked out of the White House, Canadian-listed mortgage giant Pineapple Financial announced it was rebranding as Pentiv and revealed plans to move its real estate mortgage portfolio — worth up to $10 billion — entirely onto the Injective chain.

Meanwhile, on-chain technical parameters were also being fine-tuned in lockstep with this "institutional narrative."

This week, Injective's IIP-709 governance proposal — currently up for a vote and expected to conclude tomorrow — cleanly converts all exchange-module operations, including order placement and cancellation, to a fixed gas fee.

Retail traders may be oblivious to a few cents' worth of gas fluctuation, but for traditional high-frequency market makers running tens of thousands of orders a day, lowering transaction friction costs is perhaps precisely the loyalty pledge they needed before stepping in.

So you see, from the SEC license, three ETF applications, the $10 billion mortgage portfolio going on-chain, to the fixed gas fee tailor-made for institutions, and finally walking into the White House and SEC offices...

With this entire combo executed, the narrative has changed. The concept-hype INJ of old is now wearing a full Wall Street compliance suit.

Another Round of the "Real Revenue Is Underestimated" Narrative

If the compliance backdrop above doesn't directly boost the price, then the chart INJ's official account posted yesterday looks even more like a hint — that as a crypto project with real business, it is undervalued relative to its market cap.

In this chart, which tallies data from the start of 2026 to now, Injective's "protocol revenue to fully diluted valuation ratio (Revenue/FDV)" stands at 0.95, ranking first among all mainstream public chains.

Trailing behind it are Solana (0.83) and Arbitrum (0.78).

From a real-revenue standpoint, this ratio on paper suggests INJ's current market cap is relatively small, with the subtext being more room to rise. And considering INJ also does buybacks, it's easy to read the above data as a bullish signal.

But this writer thinks it's more like a word game.

"Revenue/FDV" is a very clever division formula. To get a number that ranks first, either your numerator — real revenue — is astonishingly large, or your denominator — FDV — has fallen miserably low.

Injective's championship win rests entirely on the latter.

If you dig into the raw ledgers from Token Terminal and LunarCrush, you'll find that Injective's actual on-chain protocol revenue over the past year was only about $6 million, with cumulative total fees over the past three years amounting to just $5.9 million — placing it outside the top ten in absolute earning power among mainstream L1 public chains, not even a fraction of Ethereum ($3.8 billion) or Solana ($1.6 billion).

The reason it can crush the field on the "revenue-to-valuation ratio" is purely that its token price crashed 85% over the past two years, hammering its FDV denominator down to a mere $800–900 million.

Using a shrunken pool of under $1 billion to compete with Ethereum's hundreds-of-billions valuation on "payback rate" is, in essence, a masterclass in numerical PR gamesmanship.

More intriguingly, in the comments section of CoinGecko's tweet today announcing INJ's gain, a veteran player directly posted a screenshot from Cosmos block explorer Mintscan, piercing through another veil:

"Why do all the major market data sites list INJ's max supply as 100 million and fully circulating, but Mintscan shows an actual on-chain total supply that has already reached 123 million?"

This is the rarely mentioned B-side behind many tokens' deflation mechanisms:

Although Injective loudly conducts buyback-and-burn campaigns every month, as a PoS public chain, it must continuously mint new coins at a dynamic inflation rate at the base layer to maintain node security and attractive staking yields.

So it's quite possible that the $6 million in real annual revenue burned on-chain simply can't outpace the rate at which the staking money printer churns out new coins.

Old Tree, New Blossoms — How Far Can It Go?

Putting the bullish narrative and on-chain data side by side, the logic behind INJ's nearly 70% monthly surge becomes crystal clear:

A small, oversold pool, boosted by a compliance narrative.

Even if its real on-chain revenue remains thin, hot money and sidelined contract funds will still tend to pile in, short-term squeezing out green candle after green candle. And with the IIP-709 fixed gas fee proposal mentioned above set to conclude its vote tomorrow, short-term bullish sentiment may continue to seesaw above $9.

But for retail traders, the real significance of understanding this "White House makeover" is this: you can applaud the team's top-tier political-business PR and market manipulation skills, but never treat the attractive revenue/FDV ratio as a reason to FOMO.

With no further market-cap catalysts on the horizon, the short term warrants more attention to token structure — namely changes in open interest and funding rates, as well as whale on-chain deposit/withdrawal behavior around INJ.

After all, in this version of the game, hyping old coins anew is the main storyline, and more old coins could well get pumped on the back of some compliance narrative. INJ is just one of them — but certainly not the only one.